ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors

NEXT STORY
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
PREV STORY
VitalHub Announces Addition of Award-Winning Synopsis iQ to Recently Expanded Multi-Year Licensing Deal with King’s College Hospital NHS Foundation Trust
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation to Exebacase for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia, Including Right-Sided Endocarditis

author_avatar
NASDAQ Market News

Genocea Presents Follow-up Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial at ESMO Virtual Congress 2020

author_avatar
NASDAQ Market News

CureVac kündigt Late-Breaking-Posterpräsentation mit neuesten Daten anlässlich der Jahreskonferenz 2019 der American Association of Cancer Research (AACR) an

author_avatar
NASDAQ Market News